A Wimo

Summary

Affiliation: Karolinska Institutet
Country: Sweden

Publications

  1. ncbi request reprint Time spent on informal and formal care giving for persons with dementia in Sweden
    Anders Wimo
    HC Bergsjö, Box 16, S 820 70 Bergsjö, Sweden
    Health Policy 61:255-68. 2002
  2. ncbi request reprint Validity and reliability of assessments of time. Comparisons of direct observations and estimates of time by the use of the resource utilization in dementia (RUD)-instrument
    Anders Wimo
    Aging Research Center ARC, Division of Geriatric Epidemiology and Medicine, Neurotec, Karolinska Institutet, Huddinge Hospital, B84, S 141 86 Stockholm, Sweden
    Arch Gerontol Geriatr 44:71-81. 2007
  3. ncbi request reprint The magnitude of dementia occurrence in the world
    Anders Wimo
    Aging Research Center, Karolinska Institutet, Stockholm, Sweden
    Alzheimer Dis Assoc Disord 17:63-7. 2003
  4. ncbi request reprint Impact of donepezil treatment for Alzheimer's disease on caregiver time
    Anders Wimo
    Karolinska Institutet, Huddinge, Sweden
    Curr Med Res Opin 20:1221-5. 2004
  5. ncbi request reprint An estimate of the worldwide prevalence and direct costs of dementia in 2003
    A Wimo
    Division of Geriatric Epidemiology, Neurotec, Karolinska Institutet, Stockholm, Sweden
    Dement Geriatr Cogn Disord 21:175-81. 2006
  6. ncbi request reprint Cost effectiveness of cholinesterase inhibitors in the treatment of Alzheimer's disease: a review with methodological considerations
    Anders Wimo
    Division of Geriatric Epidemiology, Neurotec, Karolinska Institutet, Stockholm, Sweden
    Drugs Aging 21:279-95. 2004
  7. ncbi request reprint Economic aspects on drug therapy of dementia
    A Wimo
    Department of Neurotec, Aging Research Center, Karolinska Institute, Stockholm, Sweden
    Curr Pharm Des 10:295-301. 2004
  8. ncbi request reprint Societal burden and economics of vascular dementia: preliminary results from a Swedish-population-based study
    Anders Wimo
    Neurotec, Division of Geriatric Epidemiology, Karolinska Institutet, Stockholm, Sweden
    Int Psychogeriatr 15:251-6. 2003
  9. ncbi request reprint An economic evaluation of donepezil in mild to moderate Alzheimer's disease: results of a 1-year, double-blind, randomized trial
    Anders Wimo
    Department of Family Medicine, Umea University, Umea, Sweden
    Dement Geriatr Cogn Disord 15:44-54. 2003
  10. ncbi request reprint [Can the costs of future needs of health and social services for the elderly be calculated?]
    A Wimo
    Institutionen för folkhälsa och klinisk medicin, enheten för allmänmedicin, Umea Universitet
    Lakartidningen 98:4042-8. 2001

Detail Information

Publications42

  1. ncbi request reprint Time spent on informal and formal care giving for persons with dementia in Sweden
    Anders Wimo
    HC Bergsjö, Box 16, S 820 70 Bergsjö, Sweden
    Health Policy 61:255-68. 2002
    ..Some carers do carry a very heavy 24 h responsibility. This aspect of caring must be addressed by the development of well-targeted respite and relief support programmes...
  2. ncbi request reprint Validity and reliability of assessments of time. Comparisons of direct observations and estimates of time by the use of the resource utilization in dementia (RUD)-instrument
    Anders Wimo
    Aging Research Center ARC, Division of Geriatric Epidemiology and Medicine, Neurotec, Karolinska Institutet, Huddinge Hospital, B84, S 141 86 Stockholm, Sweden
    Arch Gerontol Geriatr 44:71-81. 2007
    ..9). There was a high correlation between interview-based data and register data regarding hospital care, family physician, and district nurse visits. In conclusion, interviews may serve as a valid and reliable substitute for observations...
  3. ncbi request reprint The magnitude of dementia occurrence in the world
    Anders Wimo
    Aging Research Center, Karolinska Institutet, Stockholm, Sweden
    Alzheimer Dis Assoc Disord 17:63-7. 2003
    ..In conclusion, the majority of demented elders live in less developed regions, and this proportion will increase considerably in the future...
  4. ncbi request reprint Impact of donepezil treatment for Alzheimer's disease on caregiver time
    Anders Wimo
    Karolinska Institutet, Huddinge, Sweden
    Curr Med Res Opin 20:1221-5. 2004
    ..To assess the impact of donepezil treatment compared with placebo on caregiver time spent assisting patients with Alzheimer's disease (AD)...
  5. ncbi request reprint An estimate of the worldwide prevalence and direct costs of dementia in 2003
    A Wimo
    Division of Geriatric Epidemiology, Neurotec, Karolinska Institutet, Stockholm, Sweden
    Dement Geriatr Cogn Disord 21:175-81. 2006
    ..Although there are several sources of uncertainty, it is obvious that the worldwide costs are substantial and the expected increase in elderly people in the developing countries presents a great challenge...
  6. ncbi request reprint Cost effectiveness of cholinesterase inhibitors in the treatment of Alzheimer's disease: a review with methodological considerations
    Anders Wimo
    Division of Geriatric Epidemiology, Neurotec, Karolinska Institutet, Stockholm, Sweden
    Drugs Aging 21:279-95. 2004
    ....
  7. ncbi request reprint Economic aspects on drug therapy of dementia
    A Wimo
    Department of Neurotec, Aging Research Center, Karolinska Institute, Stockholm, Sweden
    Curr Pharm Des 10:295-301. 2004
    ..Available data show that there is support for a view that treatment is cost-neutral or perhaps cost saving which in combination with positive effects in terms of efficacy may indicate cost-effectiveness...
  8. ncbi request reprint Societal burden and economics of vascular dementia: preliminary results from a Swedish-population-based study
    Anders Wimo
    Neurotec, Division of Geriatric Epidemiology, Karolinska Institutet, Stockholm, Sweden
    Int Psychogeriatr 15:251-6. 2003
    ..The cost from a societal perspective was 23% higher for patients with VaD compared with patients with Alzheimer's disease ( p = .02)...
  9. ncbi request reprint An economic evaluation of donepezil in mild to moderate Alzheimer's disease: results of a 1-year, double-blind, randomized trial
    Anders Wimo
    Department of Family Medicine, Umea University, Umea, Sweden
    Dement Geriatr Cogn Disord 15:44-54. 2003
    ....
  10. ncbi request reprint [Can the costs of future needs of health and social services for the elderly be calculated?]
    A Wimo
    Institutionen för folkhälsa och klinisk medicin, enheten för allmänmedicin, Umea Universitet
    Lakartidningen 98:4042-8. 2001
    ..Informal care of demented persons is about 4-5 times more extensive than formal care. There is a strong correlation between GNP per citizen and resources spent on health care...
  11. ncbi request reprint A 1-year, randomized, placebo-controlled study of donepezil in patients with mild to moderate AD
    B Winblad
    Karolinska Institutet, Alzheimer s Disease Research Center, Division of Geriatric Medicine, Huddinge Hospital B, Stockholm, Sweden
    Neurology 57:489-95. 2001
    ..To evaluate the long-term clinical efficacy and safety of donepezil versus placebo over 1 year in patients with mild to moderate AD...
  12. doi request reprint Incremental patterns in the amount of informal and formal care among non-demented and demented elderly persons: results from a 3-year follow-up population-based study
    A Wimo
    Alzheimer Disease Research Center KI ADRC, Karolinska Institutet, Stockholm, Sweden
    Int J Geriatr Psychiatry 26:56-64. 2011
    ....
  13. ncbi request reprint IPECAD5--Fifth International Pharmaco-Economic Conference on Alzheimer's Disease
    A Gustavsson
    KI Alzheimer s Disease Research Center, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Novum Plan 5, 141 86 Stockholm, Sweden
    J Nutr Health Aging 14:358-60. 2010
    ....
  14. ncbi request reprint 3-year study of donepezil therapy in Alzheimer's disease: effects of early and continuous therapy
    B Winblad
    Karolinska University Hospital Huddinge, Stockholm, Sweden
    Dement Geriatr Cogn Disord 21:353-63. 2006
    ..These data support the long-term efficacy and safety of donepezil...
  15. doi request reprint Costs explained by function rather than diagnosis--results from the SNAC Nordanstig elderly cohort in Sweden
    C Lindholm
    Department of Health Economics, Stockholm School of Economics, Stockholm, Sweden
    Int J Geriatr Psychiatry 28:454-62. 2013
    ..Because the prevalence of many brain disorders rises with age, and brain disorders are costly, the economic burden of brain disorders will increase markedly during the next decades...
  16. ncbi request reprint The amount of informal and formal care among non-demented and demented elderly persons-results from a Swedish population-based study
    G Nordberg
    Aging Research Center ARC, Box 6401, 113 82 Stockholm, Sweden
    Int J Geriatr Psychiatry 20:862-71. 2005
    ..Knowledge regarding the amount of formal and informal care and its interaction at population-based level is limited...
  17. ncbi request reprint Assessing the societal impact of acetylcholinesterase inhibitor therapies
    B Winblad
    Department of Clinical Neuroscience, Occupational Therapy and Elderly Care, Karolinska Institute, Stockholm, Sweden
    Alzheimer Dis Assoc Disord 13:S9-19. 1999
    ..Thus, the health economics of dementia is an extremely complex area of study that is rapidly growing, due to the likelihood that cost-effectiveness will form the basis for future reimbursement decisions...
  18. ncbi request reprint The Resource Utilization in Dementia (RUD) instrument is valid for assessing informal care time in community-living patients with dementia
    A Wimo
    KI Alzheimer s Disease Research Center, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden
    J Nutr Health Aging 14:685-90. 2010
    ..Thus it is fundamental that assessments of informal care are valid. Thus the aim was to analyse the validity of time estimates with the Resource Utilization in Dementia (RUD) instrument...
  19. ncbi request reprint Cost of illness due to dementia in Sweden
    A Wimo
    Department of Geriatric Medicine, Karolinska Institute, Stockholm, Sweden
    Int J Geriatr Psychiatry 12:857-61. 1997
    ..The gross cost of illness due to dementia was estimated to be SEK30.7 billion in 1991 while the net cost was estimated to be SEK20 billion. The sensitivity analysis showed a variation between SEK20 billion and SEK36 billion in 1991...
  20. doi request reprint The economic impact of dementia in Europe in 2008-cost estimates from the Eurocode project
    A Wimo
    Alzheimeŕs Disease Research Center, NCS, Karolinska Institute, Stockholm, Sweden
    Int J Geriatr Psychiatry 26:825-32. 2011
    ..Eurocode was administered by Alzheimer Europe. The aim was to describe the economic impact of dementia in Europe in 2008...
  21. ncbi request reprint Health economic evaluation of treatments for Alzheimer's disease: impact of new diagnostic criteria
    A Wimo
    Department of Neurobiology, Care Sciences and Society, Alzheimer s Disease Research Center, Karolinska Institutet, Stockholm, Sweden Centre for Research and Development, Uppsala University County of Gävleborg, Gavle, Sweden
    J Intern Med 275:304-16. 2014
    ..Finally, the ethical consequences of early diagnosis should be considered. ..
  22. ncbi request reprint Cost analysis of incisional hernia repair by suture or mesh
    L A Israelsson
    Department of Surgery and Perioperative Science, Umea University, Umea, Sweden
    Hernia 7:114-7. 2003
    ..For retired patients, the total costs with a mesh repair were 1,898 SEK lower than with a suture repair. We conclude that in this setting, mesh repair of incisional hernias produced lower costs than suture repair...
  23. ncbi request reprint Underweight, weight loss and related risk factors among older adults in sheltered housing--a Swedish follow-up study
    A G Mamhidir
    Division of Gerontological Caring Science, Neurotec Department, Karolenska Institetutet, Stockholm, Sweden
    J Nutr Health Aging 10:255-62. 2006
    ..Underweight and weight loss are important factors in detecting malnutrition...
  24. ncbi request reprint Outcome measures in Alzheimer's disease: do they go far enough?
    B Winblad
    Karolinska Institutet, Alzheimer Research Center, Department of Clinical Neuroscience, Huddinge University Hospital, Sweden
    Dement Geriatr Cogn Disord 11:3-10. 2000
    ....
  25. ncbi request reprint Caregiver preference for rivastigmine patch relative to capsules for treatment of probable Alzheimer's disease
    Bengt Winblad
    Karolinska Institutet Alzheimer Research Center, Huddinge, Sweden
    Int J Geriatr Psychiatry 22:485-91. 2007
    ..Transdermal patches may offer advantages over conventional oral formulations...
  26. ncbi request reprint Cost-effectiveness of a multidisciplinary intervention model for community-dwelling frail older people
    René J F Melis
    Radboud University Nijmegen Medical Centre, Department of Geriatric Medicine, Nijmegen, The Netherlands
    J Gerontol A Biol Sci Med Sci 63:275-82. 2008
    ..This article reports about the cost-effectiveness of the Dutch Geriatric Intervention Program (DGIP) compared to usual care in frail older people at 6-month follow-up from a health care system's point of view...
  27. pmc Alzheimer's disease and vascular dementia in developing countries: prevalence, management, and risk factors
    Raj N Kalaria
    Institute for Ageing and Health, Newcastle General Hospital, Newcastle upon Tyne, UK
    Lancet Neurol 7:812-26. 2008
    ..Dementia costs in developing countries are estimated to be US$73 billion yearly, but care demands social protection, which seems scarce in these regions...
  28. ncbi request reprint A longitudinal study integrating population, care and social services data. The Swedish National study on Aging and Care (SNAC)
    Marten Lagergren
    Stockholm Gerontology Research Center, Stockholm, Sweden
    Aging Clin Exp Res 16:158-68. 2004
    ..A large, national, long-term, longitudinal, multi-purpose study has been launched in Sweden--the Swedish National study on Aging and Care (SNAC). The study involves four research centers collecting data in four different areas of Sweden...
  29. ncbi request reprint Resource utilisation and cost analysis of memantine in patients with moderate to severe Alzheimer's disease
    Anders Wimo
    Division of Geriatric Epidemiology Sector of Health Economy, Neurotec, Karolinska Institute, Huddinge, Sweden
    Pharmacoeconomics 21:327-40. 2003
    ..Alzheimer's disease (AD) is a devastating illness that causes enormous emotional stress to affected families and is associated with substantial medical and nonmedical costs...
  30. ncbi request reprint Pharmacoeconomics of mild cognitive impairment
    Anders Wimo
    Division of Geriatric Medicine, Neurotec, Karolinska Institutet, Stockholm, Sweden
    Acta Neurol Scand Suppl 179:94-9. 2003
    ..From the Kungsholmen project in Sweden, there are indications that the postponement between MCI and manifest dementia may result in short-term benefits (a few years) of about SEK50,000 (5300 US dollars)...
  31. ncbi request reprint Assessment of Health Economics in Alzheimer's Disease (AHEAD): treatment with galantamine in Sweden
    Frances B Garfield
    Caro Research Institute, Concord, Massachusetts 01742, USA
    Pharmacoeconomics 20:629-37. 2002
    ..Galantamine, a new acetylcholinesterase inhibitor and nicotinic modulator, has proved effective in managing patients with Alzheimer's disease in clinical trials...
  32. ncbi request reprint Clinical and economic outcomes--friend or foe?
    Anders Wimo
    Department of Neurobiology, Care and Society, Karolinska University Hospital, Stockholm, Sweden
    Int Psychogeriatr 19:497-507. 2007
    ..Both dementia-specific and generic quality of life instruments are required. Models are necessary but must be transparent so that the assumptions on which the models are built can be critically analyzed...
  33. ncbi request reprint The association of inappropriate drug use with hospitalisation and mortality: a population-based study of the very old
    Inga Klarin
    Division of Geriatric Epidemiology, Neurotec, Karolinska Institutet, Stockholm, Sweden
    Drugs Aging 22:69-82. 2005
    ..The aim of this study was to explore possible associations of IDU with acute hospitalisation and mortality in an elderly population during 3 years of follow-up...
  34. ncbi request reprint Patient- and proxy-reported utility in Alzheimer disease using the EuroQoL
    Linus Jönsson
    Neurotec, Section for Geriatric Epidemiology, Karolinska Institutet, Stockholm, Sweden
    Alzheimer Dis Assoc Disord 20:49-55. 2006
    ..The study shows that the EuroQoL can be used to rate utilities in Alzheimer disease, but there are important differences between patient- and proxy-ratings...
  35. ncbi request reprint Determinants of costs of care for patients with Alzheimer's disease
    Linus Jönsson
    Division of Geriatric Epidemiology, The Neurotec Department, Karolinska Institutet, Stockholm, Sweden
    Int J Geriatr Psychiatry 21:449-59. 2006
    ..Alzheimer's disease (AD), the most common cause of dementia, is a major cause of disability and care burden in the elderly. This study aims to estimate the costs of formal and informal care and identity determinants of care costs...
  36. ncbi request reprint The use of angiotensin-converting enzyme inhibitors and other drugs with cardiovascular effects by non-demented and demented elderly with a clinical diagnosis of heart failure. A population-based study of the very old
    Inga Klarin
    Aging Research Center, Division of Geriatric Epidemiology, Neurotec, Karolinska Institutet, Gavlegatan 16, 113 30, Stockholm, Sweden
    Eur J Clin Pharmacol 62:555-62. 2006
    ..The aim of this study was to investigate drug treatment patterns for heart failure (HF) in the very elderly and, in particular, to determine if angiotensin-converting enzyme inhibitors (ACEIs) were under-used by demented persons...
  37. ncbi request reprint A population-based study of drug use in the very old living in a rural district of Sweden, with focus on cardiovascular drug consumption: comparison with an urban cohort
    Inga Klarin
    Division of Geriatric Epidemiology, Neurotec, Karolinska Institutet, Sweden
    Pharmacoepidemiol Drug Saf 12:669-78. 2003
    ..To describe drug use among the elderly, with focus on cardiovascular drugs and regional differences...
  38. ncbi request reprint More illness and less disease? A 20-year perspective on chronic disease and medication
    Bertil Hagstrom
    Department of Primary Health Care, Goteborg University, Goteborg, Sweden
    Scand J Public Health 34:584-8. 2006
    ..Aims: To investigate the apprehension in respect of chronic disease among the working population in a Swedish community in 2000 compared with 1980...
  39. ncbi request reprint Health utilities in mild cognitive impairment and dementia: a population study in Sweden
    Mattias Ekman
    Stockholm Health Economics, Stockholm, Sweden
    Int J Geriatr Psychiatry 22:649-55. 2007
    ..To collect new primary data on community-based health utilities (time trade-off values) in different stages of mild cognitive impairment and dementia from a general population sample...
  40. ncbi request reprint Time use and costs of institutionalised elderly persons with or without dementia: results from the Nordanstig cohort in the Kungsholmen Project--a population based study in Sweden
    Gunilla Nordberg
    Aging Research Center ARC, Karolinska Institutet, Stockholm, Sweden
    Int J Geriatr Psychiatry 22:639-48. 2007
    ..The aging of the population has become a worldwide phenomenon. This leads to increased demand for services and with limited resources it is important to find a way to estimate how resources can be match to those with greatest need...
  41. ncbi request reprint [There is a need to reform dementia care. Resources are not used optimally--time for evidence-based care]
    Jan Marcusson
    Geriatriska kliniken, Universitetssjukhuset i Linköping
    Lakartidningen 103:1022-4, 1027-8. 2006
  42. ncbi request reprint Older patients awaiting emergency department treatment
    Annica Larsson Kihlgren
    Centre for Nursing Science, Orebro University Hospital, Orebro, Sweden
    Scand J Caring Sci 18:169-76. 2004
    ..The way, in which nursing care was carried out, which in this context is discussed in terms of praxis and poieses, appeared to be of major importance for the older peoples' experiences when visiting the ED...